0

Biotechnology Market: Current Analysis and Forecast (2021-2027)

Region:Global

Author(s):

Product Code:UMHE21303

Download Sample Report download
Buy the Full ReportStarting from $3500
Published on

July 2021

Total pages

108

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $3500

About the Report

About the Report

Biotechnology is interdisciplinary, that uses living creatures, biological systems, or derivatives to modify or develop processes and outcomes for the development of healthcare goods and medicines. It has a significant impact on a variety of industries, including medicine and pharmaceuticals, genetics, food and chemical production, and others.

The growth of the biotechnology sector in developing countries like India and China, their market is being driven by favourable government initiatives. Government activities are aimed at modernizing the medicines regulatory system, standardizing clinical trials, enhancing reimbursement rules, and expediting the product approval process, all of which promise attractive development potential. Small molecules dominated the pharmaceutical compounds pipeline with around 22 U.S. FDA approvals as compared to eight large molecules (biotech). Around 4 out of every 10 drugs are biotech derived, which can be attributed to the growing demand for orphan drugs and personalized medicine.

Moreover, agricultural companies are concentrating their efforts on bringing agricultural innovations tomarket to boost production through long-term solutions. For example, BASF said in February 2020 that by 2029, it will have launched more than 30 initiatives aimed at producing novel seeds, traits, biological and chemical crop protection solutions, new formulations, and digital products. However, risks associated with hereditary information can prevent the market to grow in the coming years.

Based on technology, the market is fragmented nanobiotechnology, tissue engineering & regeneration, DNA sequencing, cell-based assays, fermentation, PCR technology, chromatography, and others. The nanotechnology segment generated revenue of USD XX billion in 2020. The market is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX billion by 2027F owing to the continuous advancements and wide range of applications.

Based on the application, the market is fragmented into bio-pharmacy, bio-services, bio-agriculture, bio-industrial, and bioinformatics. The bio-agriculture segment generated revenue of USD XX billion in 2020 and is anticipated to reach USD XX billion by the year 2027F, growing at a CAGR of XX% over the forecast period (2021-2027). Growing demand for food with increasing population and rising adoption of Genetically Modified (GM) crops is likely to fuel the bio-agriculture segment.

For a better understanding of the market adoption of the Biotechnology market, the market is analysed based on its worldwide penetration in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the Biotechnology industry and generated revenue of USD XX billion in 2020 owing to the presence of key players, extensive R&D activities, and high healthcare expenditure, etc., However, the Asia Pacific region would grow at the highest rate during the forecast period.

Some of the major players operating in the market include Abbott Laboratories, Amgen, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, Illumina, Merck, PerkinElmer, Qiagen, Thermo Fisher Scientific, etc. Several M&A's along with partnerships have been undertaken by these players to boost their presence in different regions.

Products


Companies

Abbott Laboratories, Amgen, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, Illumina, Merck, PerkinElmer, Qiagen, and Thermo Fisher Scientific

Table of Contents

Table of Contents

1 MARKET INTRODUCTION

1.1 Market Definitions

1.2 Objective of the Study

1.3 Limitation

1.4 Stake Holders

1.5 Currency Used in Report

1.6 Scope of the Global Biotechnology Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1 Research Methodology for the Global Biotechnology Market

2.1.1 Main Objective of the Global Biotechnology Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPs UNDER BIOTECHNOOGY INDUSTRY

6 COVID-19 IMPACT

7 GLOBAL BIOTECHNOLOGY MARKET REVENUE

8 MARKET INSIGHTS BY TECHNOLOGY

8.1 Nanobiotechnology

8.2 Tissue engineering & regeneration

8.3 DNA sequencing

8.4 Cell-based assays

8.5 Fermentation

8.6 PCR technology

8.7 Chromatography

8.8 Others

9 MARKET INSIGHTS BY APPLICATION

9.1 Bio-pharmacy

9.2 Bio-services

9.3 Bio-agriculture

9.4 Bio-industrial

9.5 Bioinformatics

11 MARKET INSIGHTS BY REGION

11.1 NORTH AMERICA BIOTECHNOLOGY MARKET

11.1.1 United States

11.1.2 Canada

11.1.3 Rest of North America

11.2 EUROPE BIOTECHNOLOGY MARKET

11.2.1 Germany

11.2.2 France

11.2.3 United Kingdom

11.2.4 Spain

11.2.5 Italy

11.2.6 Rest of Europe

11.3 ASIA PACIFIC BIOTECHNOLOGY MARKET

11.3.1 China

11.3.2 Japan

11.3.3 India

11.3.4 Australia

11.3.5 South Korea

11.3.6 Rest of Asia Pacific

11.4 REST OF THE WORLD BIOTECHNOLOGY MARKET

12 BIOTECHNOLOGY MARKET DYNAMICS

12.1 Market Drivers

12.2 Market Challenges

12.3 Impact Analysis

13 LEGAL & REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY SIDE ANALYSIS

14.1 Demand Side Analysis

14.2 Supply Side Analysis

14.2.1 Top Product Launches

14.2.2 Top Business Partnerships

14.2.3 Top Merger & Acquisitions

15 VALUE CHAIN ANALYSIS

16 BIOTECHNOLOGY MARKET OPPORTUNITIES

17 BIOTECHNOLOGY MARKET TRENDS & INSIGHTS

18 COMPETITIVE SCENARIO

18.1 Porter's Five forces analysis

18.1.1 Bargaining power of Supplier

18.1.2 Bargaining power of Buyer

18.1.3 Industry Rivalry

18.1.4 Availability of Substitute

18.1.5 Threat of new Entrants

19 COMPANY PROFILED

19.1 Thermo Fisher Scientific

19.1.1 Key Facts

19.1.2 Business Description

19.1.3 Key Product/Services Offerings

19.1.4 Growth Strategy

19.1.5 SWOT Analysis

19.1.6 Key Financials

19.1.6.1

19.1.6.2

19.1.7 Recent Developments

19.1.7.1

19.1.7.2

19.1.7.3

19.1.7.4

19.2 Abbott Laboratories

19.3 Amgen

19.4 Bio-Rad Laboratories

19.5 Danaher

19.6 F. Hoffmann-La Roche

19.7 Illumina

19.8 Merck

19.9 PerkinElmer

19.10 Qiagen

20 DISCLAIMER

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022